116 related articles for article (PubMed ID: 6339850)
1. Immunobiologic staging of patients with carcinoma of the head and neck.
Katz AE
Laryngoscope; 1983 Apr; 93(4):445-63. PubMed ID: 6339850
[TBL] [Abstract][Full Text] [Related]
2. Immunologic evaluation and prognosis in patients with head and neck cancer.
Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF
Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057
[TBL] [Abstract][Full Text] [Related]
3. Prognostic variables in head and neck cancer. Tumor site, stage, nodal status, differentiation, and immune status.
Davis RK
Otolaryngol Clin North Am; 1985 Aug; 18(3):411-9. PubMed ID: 4047665
[TBL] [Abstract][Full Text] [Related]
4. Serum immunoglobulin E levels in patients with head and neck cancer.
Lal H; Singh B; Wig U; Saini AS
J Laryngol Otol; 1988 May; 102(5):432-4. PubMed ID: 3397638
[TBL] [Abstract][Full Text] [Related]
5. Serum immunoglobulins in patients with carcinoma of the oral cavity, uterine cervix and breast.
Vijayakumar T; Ankathil R; Remani P; Sasidharan VK; Vijayan KK; Vasudevan DM
Cancer Immunol Immunother; 1986; 22(1):76-9. PubMed ID: 3708632
[TBL] [Abstract][Full Text] [Related]
6. Serum immunoglobulin levels in patients with head and neck cancer (IgE, IgA, IgM, IgG).
Vinzenz K; Pavelka R; Schönthal E; Zekert F
Oncology; 1986; 43(5):316-22. PubMed ID: 3763126
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tract.
Gilbert HA; Kagan AR; Miles J; Flores L; Nussbaum H; Rao AR; Chan P
J Surg Oncol; 1978; 10(1):73-7. PubMed ID: 628221
[TBL] [Abstract][Full Text] [Related]
8. An immunologic profile of young adults with head and neck cancer.
Schantz SP; Liu FJ
Cancer; 1989 Sep; 64(6):1232-7. PubMed ID: 2569924
[TBL] [Abstract][Full Text] [Related]
9. [Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)].
Bier J; Nicklisch U
Arch Otorhinolaryngol; 1981; 232(2):145-63. PubMed ID: 6973965
[TBL] [Abstract][Full Text] [Related]
10. On the immunology of head and neck cancer--a prognostic index. Preliminary communication.
Parker R; Alexander S; Shaheen OH; Parkes P
J Laryngol Otol; 1975 Jul; 89(7):687-95. PubMed ID: 1185059
[TBL] [Abstract][Full Text] [Related]
11. Nonspecific immune determinants in the patient with unresectable gastrointestinal carcinoma.
Moertel CG; Ritts RE; O'Connell MJ; Silvers A
Cancer; 1979 Apr; 43(4):1483-92. PubMed ID: 376093
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of patients with infectious forms of syphilis and changes in their immunological reactivity].
Chistiakova AM; Reznikova LS
Vestn Dermatol Venerol; 1975 Aug; (8):86-90. PubMed ID: 1101559
[No Abstract] [Full Text] [Related]
13. Alterations in T-lymphocyte subpopulations in patients with head and neck cancer. Correlations with prognosis.
Wolf GT; Schmaltz S; Hudson J; Robson H; Stackhouse T; Peterson KA; Poore JA; McClatchey KD
Arch Otolaryngol Head Neck Surg; 1987 Nov; 113(11):1200-6. PubMed ID: 3499156
[TBL] [Abstract][Full Text] [Related]
14. Immunocompetence testing in patients with one of the four common operable cancers--a review.
Wanebo HJ; Pinsky CM; Beattie EJ; Oettgen HF
Clin Bull; 1978; 8(1):15-22. PubMed ID: 668106
[No Abstract] [Full Text] [Related]
15. Immunoglobulins G, M, A, D and E in Behcet's syndrome.
Scully C; Boyle P; Yap PL
Clin Chim Acta; 1982 Apr; 120(2):237-42. PubMed ID: 7067147
[TBL] [Abstract][Full Text] [Related]
16. An immunological outcome predictive score for head and neck carcinoma patients.
Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D
Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
[TBL] [Abstract][Full Text] [Related]
17. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
Maisel RH; Ogura JH
Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
[TBL] [Abstract][Full Text] [Related]
18. Immunologic determinants of head and neck cancer response to induction chemotherapy.
Schantz SP; Savage HE; Racz T; Liu FJ; Brown BW; Rossen RD; Hong WK
J Clin Oncol; 1989 Jul; 7(7):857-64. PubMed ID: 2472470
[TBL] [Abstract][Full Text] [Related]
19. Sequential evaluation of immunoreactivity in patients with melanoma undergoing surgery and adjuvant therapy.
Dionigi R; Dominioni L; Gnes F; Bonera A; Prati U; Scarponi A; Robustelli Della Cuna G; Pavesi L; Campani M
Tumori; 1980 Feb; 66(1):59-76. PubMed ID: 6966434
[TBL] [Abstract][Full Text] [Related]
20. Major immunoglobulin ratios in carcinoma of the head and neck.
Katz AE; Nysather JO; Harker LA
Ann Otol Rhinol Laryngol; 1978; 87(3 Pt 1):412-5. PubMed ID: 655583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
